Immutep Director Increases Shareholding

TipRanks10:07

Immutep Ltd (PRRUF) Gets a Buy From Bell Potter

TipRanksSep 18 22:05 · Ratings

Immutep To Present New Data From EFTISARC-NEO Phase II Evaluating Novel Triple Combination Including Efti In Soft Tissue Sarcoma

BenzingaSep 18 20:09

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and Immutep Ltd (OtherPRRUF)

TipRanksSep 18 09:11 · Ratings

Immutep's Efti Shows Promise in Cancer Therapy

TipRanksSep 17 18:29

Immutep Price Target Cut 6.7% to A$0.70/Share by Bell Potter

Dow JonesSep 17 06:11 · Ratings